269 related articles for article (PubMed ID: 28490863)
1. Development and evaluation of a new modular nanotransporter for drug delivery into nuclei of pathological cells expressing folate receptors.
Slastnikova TA; Rosenkranz AA; Khramtsov YV; Karyagina TS; Ovechko SA; Sobolev AS
Drug Des Devel Ther; 2017; 11():1315-1334. PubMed ID: 28490863
[TBL] [Abstract][Full Text] [Related]
2. Preparation, cytotoxicity, and in vivo antitumor efficacy of
Slastnikova TA; Rosenkranz AA; Morozova NB; Vorontsova MS; Petriev VM; Lupanova TN; Ulasov AV; Zalutsky MR; Yakubovskaya RI; Sobolev AS
Int J Nanomedicine; 2017; 12():395-410. PubMed ID: 28138237
[TBL] [Abstract][Full Text] [Related]
3. Antitumor efficacy of Auger electron emitter
Rosenkranz AA; Slastnikova TA; Khramtsov YV; Karyagina TS; Georgiev GP; Sobolev AS
Dokl Biochem Biophys; 2017 Mar; 473(1):85-87. PubMed ID: 28510138
[TBL] [Abstract][Full Text] [Related]
4. Modular nanotransporters: a multipurpose in vivo working platform for targeted drug delivery.
Slastnikova TA; Rosenkranz AA; Gulak PV; Schiffelers RM; Lupanova TN; Khramtsov YV; Zalutsky MR; Sobolev AS
Int J Nanomedicine; 2012; 7():467-82. PubMed ID: 22346349
[TBL] [Abstract][Full Text] [Related]
5. Antitumor Activity of Auger Electron Emitter
Rosenkranz AA; Slastnikova TA; Karmakova TA; Vorontsova MS; Morozova NB; Petriev VM; Abrosimov AS; Khramtsov YV; Lupanova TN; Ulasov AV; Yakubovskaya RI; Georgiev GP; Sobolev AS
Front Pharmacol; 2018; 9():1331. PubMed ID: 30510514
[TBL] [Abstract][Full Text] [Related]
6. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y
Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995
[TBL] [Abstract][Full Text] [Related]
7. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.
Qiu LY; Yan L; Zhang L; Jin YM; Zhao QH
Int J Pharm; 2013 Nov; 456(2):315-24. PubMed ID: 24016742
[TBL] [Abstract][Full Text] [Related]
8. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
[TBL] [Abstract][Full Text] [Related]
9. Modular nanotransporters: a versatile approach for enhancing nuclear delivery and cytotoxicity of Auger electron-emitting 125I.
Slastnikova TA; Koumarianou E; Rosenkranz AA; Vaidyanathan G; Lupanova TN; Sobolev AS; Zalutsky MR
EJNMMI Res; 2012 Oct; 2(1):59. PubMed ID: 23107475
[TBL] [Abstract][Full Text] [Related]
10. Folate-targeting annonaceous acetogenins nanosuspensions: significantly enhanced antitumor efficacy in HeLa tumor-bearing mice.
Li H; Li Y; Ao H; Bi D; Han M; Guo Y; Wang X
Drug Deliv; 2018 Nov; 25(1):880-887. PubMed ID: 29608108
[TBL] [Abstract][Full Text] [Related]
11. Radiolabeling and in vitro evaluation of (67)Ga-NOTA-modular nanotransporter--a potential Auger electron emitting EGFR-targeted radiotherapeutic.
Koumarianou E; Slastnikova TA; Pruszynski M; Rosenkranz AA; Vaidyanathan G; Sobolev AS; Zalutsky MR
Nucl Med Biol; 2014 Jul; 41(6):441-9. PubMed ID: 24776093
[TBL] [Abstract][Full Text] [Related]
12. The folate receptor as a rational therapeutic target for personalized cancer treatment.
Assaraf YG; Leamon CP; Reddy JA
Drug Resist Updat; 2014; 17(4-6):89-95. PubMed ID: 25457975
[TBL] [Abstract][Full Text] [Related]
13. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity.
Patil Y; Amitay Y; Ohana P; Shmeeda H; Gabizon A
J Control Release; 2016 Mar; 225():87-95. PubMed ID: 26809007
[TBL] [Abstract][Full Text] [Related]
14. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F
Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496
[TBL] [Abstract][Full Text] [Related]
15. Modular Nanotransporters for Nuclear-Targeted Delivery of Auger Electron Emitters.
Sobolev AS
Front Pharmacol; 2018; 9():952. PubMed ID: 30210340
[TBL] [Abstract][Full Text] [Related]
16. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.
Goren D; Horowitz AT; Tzemach D; Tarshish M; Zalipsky S; Gabizon A
Clin Cancer Res; 2000 May; 6(5):1949-57. PubMed ID: 10815920
[TBL] [Abstract][Full Text] [Related]
17. New Recombinant Carriers Binding Specifically to the Epidermal Growth Factor Receptor.
Karyagina TS; Ulasov AV; Rosenkranz AA; Slastnikova TA; Khramtsov YV; Lupanova TN; Georgiev GP; Sobolev AS
Dokl Biochem Biophys; 2020 Jan; 490(1):22-24. PubMed ID: 32342307
[TBL] [Abstract][Full Text] [Related]
18. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
[TBL] [Abstract][Full Text] [Related]
19. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells.
Tong L; Chen W; Wu J; Li H
Anticancer Drugs; 2014 Mar; 25(3):244-54. PubMed ID: 24275314
[TBL] [Abstract][Full Text] [Related]
20. Relevance of folic acid/polymer ratio in targeted PEG-epirubicin conjugates.
Canal F; Vicent MJ; Pasut G; Schiavon O
J Control Release; 2010 Sep; 146(3):388-99. PubMed ID: 20621587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
